In a 14-1 vote, the Advisory Committee on Immunization Practices (ACIP) recommended lowering the age recommendation for all pneumococcal conjugate vaccines (PCVs) to people 50 years of age and older, regardless of their risk.
In addition, vaccination is recommended for adults ages 19 to 49 years with certain underlying conditions or risk factors who have not received a PCV or whose vaccination history is unknown.
The one person who voted against the recommendation was the